Primary Record
Glucosinalbin
- In stock
- 3,554 g
- Purity
- 98.8 %
- CAS
- 19253-84-0
Compound Identifiers & Properties
- CAS
- 19253-84-0
- PubChem CID
- 9601115
- SMILES
- C1=CC(=CC=C1C/C(=N\OS(=O)(=O)O)/S[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O
- Canonical SMILES
- O=S(=O)(O)O/N=C(\Cc1ccc(O)cc1)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Names & Synonyms
- Glucosinalbin
- Glucosinalbate
- Sinalbin
- Glucosinalbin-
- 4-Hydroxybenzyl glucosinolate
- MZ3RB28MCY
- Sinapine glucosinalbate
- Sinalbin,potassium salt
- p-Hydroxybenzylglucosinolate
- RefChem:143638
- UNII-MZ3RB28MCY
- 4-hydroxybenzylglucosinolate
- UNII-Z0BYE1900W
- 19253-84-0
- SCHEMBL29353956
- C14H19NO10S2
- CHEBI:189937
- EINECS 243-582-3
- AKOS040740796
- CID 415565
- CID9601115
- FG71633
- C16H24NO5.C14H18NO10S2
- J277.929C
- C16-H24-N-O5.C14-H18-N-O10-S2
- ((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl) (1E)-2-(4-hydroxyphenyl)-N-sulfooxy-ethanimidothioate
- [(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-2-(4-hydroxyphenyl)-N-sulfooxyethanimidothioate
- beta-D-Glucopyranose, 1-thio-, 1-(4-hydroxy-N-(sulfooxy)benzeneethanimidate)
- .BETA.-D-GLUCOPYRANOSE, 1-THIO-, 1-(4-HYDROXY-N-(SULFOOXY)BENZENEETHANIMIDATE)
- 1-thio-b-D-Glucopyranose 1-(4-hydroxy-N-(sulfooxy)benzeneethanimidate)
- 1-Thio-b-D-glucopyranose 1-[4-hydroxy-N-(sulfooxy)benzeneethanimidate]
- 20196-67-2
- GLUCOPYRANOSE, 1-THIO-, 1-(2-(P-HYDROXYPHENYL)ACETOHYDROXIMATE) NO-(HYDROGEN SULFATE), .BETA.-D-
- Glucopyranose, 1-thio-, 1-(2-(p-hydroxyphenyl)acetohydroximate) NO-(hydrogen sulfate), beta-D-
- 1-S-[1-[(Hydroxysulfonyloxy)imino]-2-(4-hydroxyphenyl)ethyl]-1-thio-beta-D-glucopyranose
- 1-Thio-beta-D-glucopyranose 1-[N-(hydroxysulfonyloxy)-2-(4-hydroxyphenyl)ethaneimidate]
- 1-Thio-beta-D-glucopyranose 1-[N-(hydroxysulfonyloxy)-4-hydroxybenzeneethaneimidate]
- ((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl) (1E)-2-(4-hydroxyphenyl)-N-sulfooxyethanimidothioate
- ({[2-(4-hydroxyphenyl)-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino}oxy)sulfonic acid
- [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-2-(4-hydroxyphenyl)-N-sulooxyethanimidothioate
- [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] (1E)-2-(4-hydroxyphenyl)-N-sulfooxy-ethanimidothioate
- [2-[3-(4-hydroxy-3,5-dimethoxyphenyl)acryloyloxy]ethyl]trimethylammonium, saltwith 1-thio-beta-D-glucopyranose 1-[4-hydroxy-N-(sulphooxy)phenylacetimidate] (1:1)
- [2-[3-(4-Hydroxy-3,5-Dimethoxyphenyl)acryloyloxy]ethyl]trimethylammonium,saltwith 1-thio-beta-d-glucopyranose 1-[4-hydroxy-N-(sulphooxy)phenylacetimidate](1:1)
- 3H-Pyrazol-3-one, 4,4'-[(4-hydroxyphenyl)methylene]bis[2,4-dihydro-5-methyl-2-phenyl- (en)
- 57303-43-2
- Choline, salt with 1-thio-.beta.-D-glucopyranose 1-[2-(p-hydroxyphenyl)acetohydroximate] NO-(hydrogen sulfate) (1:1), mono(4-hydroxy-3,5-dimethoxycinnamate) (ester)
- Ethanaminium, 2-[[3-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2-propenyl]oxy]-N,N,N-trimethyl-, salt with 1-thio-.beta.-D-glucopyranose 1-[4-hydroxy-N-(sulfooxy)benzeneethanimidate] (1:1)